[grow_thumb image=”http://telecareaware.com/wp-content/uploads/2016/07/Kinesia1.png” thumb_width=”150″ /]A study in the July Journal of Parkinson’s Disease
presents a small (N=40) study on the use of wearable sensor data and the KinesiaOne
mobile app to assist in clinical decisions around advanced therapy referral for Parkinson’s disease patients. The KinesiaOne sensor is worn on the fingertip and tracks motor response on the mobile app (left). The patients were followed for one year, with half receiving standard care and half using motion sensor-based remote monitoring once per month in conjunction with standard care. Remote monitoring led to five times more advanced therapy patient referrals, compared to standard care alone (63.6 percent versus 11.8 percent, p < 0.01). These therapies are highly considered due to their nature–deep brain stimulation (DBS) or an implantable medication pump–and this initial screening may lead to more advanced algorithms and/or continuous monitoring, which the KinesiaOne developer, Great Lakes NeuroTechnologies
, also has. Release
, JPD abstract
Also see our short article on Ireland’s Beats Medical
Liesel Butterfield, a young marketer/business development exec with Enterprise Ireland, focuses on three young companies with investment from EI:
- Beats Medical: an app that delivers metronome sound wave therapy, reminders and assessments to Parkinson’s disease patients. The principle is cueing and auditory stimulation which has been proven to aid these patients in maintaining mobility, reducing symptoms and a characteristic freezing of gait. In 2013 it was an Enterprise Ireland high-potential startup. Founder Ciara Clancy was named Laureate for Europe at the Cartier Women’s Initiative 2015. HQ in Dublin and London.
- DocLink is an app with a secure document management system which enables communications of text, video and images between doctors globally. It also has a newsfeed/forum that tailors information by specialty. HQ is near Dublin.
- Ayda is an app with a sensor device that adheres to your underarm . Its primary use is highly targeted to female fertility tracking. In pre-market, HQ’d in Cork and San Francisco.
LinkedIn Pulse. Hat tip to Liesel.